Free Trial
NASDAQ:AMTX

Aemetis (AMTX) Stock Price, News & Analysis

$2.21
-0.01 (-0.45%)
(As of 09/6/2024 ET)
Today's Range
$2.17
$2.25
50-Day Range
$2.21
$3.95
52-Week Range
$2.10
$7.03
Volume
320,601 shs
Average Volume
838,220 shs
Market Capitalization
$98.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.95

Aemetis MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
486.0% Upside
$12.95 Price Target
Short Interest
Bearish
14.69% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.23mentions of Aemetis in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.19) to ($0.55) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.08 out of 5 stars

Oils/Energy Sector

209th out of 239 stocks

Industrial Organic Chemicals Industry

18th out of 19 stocks

AMTX stock logo

About Aemetis Stock (NASDAQ:AMTX)

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.

AMTX Stock Price History

AMTX Stock News Headlines

Aemetis, Inc. (NASDAQ:AMTX) Sees Large Increase in Short Interest
Fmr CIA Advisor reveals PEACEMAKER superweapon
Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.
AMTX Sep 2024 5.000 put (AMTX240920P00005000)
Aemetis, Inc. (AMTX)
AMTX Jan 2026 4.500 call
Fmr CIA Advisor reveals PEACEMAKER superweapon
Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.
See More Headlines
Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/01/2024
Today
9/07/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Industrial organic chemicals
Sub-Industry
Chemicals
Current Symbol
NASDAQ:AMTX
Employees
160
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.95
High Stock Price Target
$28.00
Low Stock Price Target
$3.50
Potential Upside/Downside
+486.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-46,420,000.00
Pretax Margin
-36.40%

Debt

Sales & Book Value

Annual Sales
$278.65 million
Book Value
($5.27) per share

Miscellaneous

Free Float
38,031,000
Market Cap
$98.12 million
Optionable
Optionable
Beta
1.31
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

AMTX Stock Analysis - Frequently Asked Questions

How have AMTX shares performed this year?

Aemetis' stock was trading at $5.24 at the beginning of the year. Since then, AMTX stock has decreased by 57.8% and is now trading at $2.21.
View the best growth stocks for 2024 here
.

How were Aemetis' earnings last quarter?

Aemetis, Inc. (NASDAQ:AMTX) posted its quarterly earnings results on Thursday, August, 1st. The specialty chemicals company reported ($0.66) earnings per share for the quarter, missing the consensus estimate of ($0.41) by $0.25. The specialty chemicals company earned $66.56 million during the quarter, compared to analysts' expectations of $75.37 million.

Who are Aemetis' major shareholders?

Top institutional shareholders of Aemetis include Susquehanna Fundamental Investments LLC (0.28%), Bank of New York Mellon Corp (0.23%), Rhumbline Advisers (0.12%) and Hutchinson Capital Management CA (0.05%). Insiders that own company stock include Naomi Louise Boness, John R Block, Andrew B Foster, Timothy Alan Simon and Francis P Barton.
View institutional ownership trends
.

How do I buy shares of Aemetis?

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Aemetis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aemetis investors own include Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), Tilly's (TLYS), Auxly Cannabis Group (CBWTF) and Novan (NOVN).

This page (NASDAQ:AMTX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners